Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bakkt (BKKT) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Bakkt (BKKT) over the last 6 years, with Q3 2025 value amounting to $58.3 million.

  • Bakkt's Cash & Equivalents rose 10121.1% to $58.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.3 million, marking a year-over-year increase of 10121.1%. This contributed to the annual value of $39.0 million for FY2024, which is 2615.82% down from last year.
  • Bakkt's Cash & Equivalents amounted to $58.3 million in Q3 2025, which was up 10121.1% from $43.5 million recorded in Q2 2025.
  • In the past 5 years, Bakkt's Cash & Equivalents registered a high of $355.2 million during Q1 2022, and its lowest value of $22.1 million during Q3 2021.
  • Its 5-year average for Cash & Equivalents is $79.8 million, with a median of $54.7 million in 2023.
  • As far as peak fluctuations go, Bakkt's Cash & Equivalents skyrocketed by 62310.68% in 2022, and later crashed by 8568.85% in 2023.
  • Quarter analysis of 5 years shows Bakkt's Cash & Equivalents stood at $22.1 million in 2021, then surged by 344.82% to $98.3 million in 2022, then tumbled by 46.22% to $52.9 million in 2023, then decreased by 26.16% to $39.0 million in 2024, then surged by 49.35% to $58.3 million in 2025.
  • Its Cash & Equivalents was $58.3 million in Q3 2025, compared to $43.5 million in Q2 2025 and $23.0 million in Q1 2025.